PVG Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

PVG Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$70.5K	Buy	+10,175	New	+$85.5K	0.26%	42

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

PVG Asset Management's LUMO Position: Q4 2021 in Review

PVG Asset Management opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2021: 10,175 shares worth $70.5K. The stake represents 0.26% of the portfolio and ranks #42 among its holdings.

38 funds tracked by Wall St. Rank hold LUMO as of Q4 2021.

PVG Asset Management held 10,175 shares of Lumos Pharma, Inc. Common Stock worth $70.5K as of Q4 2021.
Lumos Pharma, Inc. Common Stock was a new PVG Asset Management position in Q4 2021.
Lumos Pharma, Inc. Common Stock made up 0.26% of PVG Asset Management's portfolio in Q4 2021, its #42 holding.
38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2021.

Based on PVG Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.